For subcutaneous vaccination of healthy cats 8 to 10 weeks of age or older, as an aid in the prevention of disease caused by feline rhinotracheitis, calici and panleukopenia viruses. The vaccine contains one additional feline calicivirus strain isolated from one hemorrhagic calicivirus outbreak that occurred in 1998 and was shown to protect vaccinated cats against calicivirus-induced hemorrhagic disease in controlled vaccination challenge experiments.

DOSE: Inject one 1 mL dose subcutaneously using aseptic technique. Repeat in 3 to 4 weeks. Annual revaccination with a single dose of vaccine is recommended.